Oncotarget is the go to English journal for all things oncology related. It has broken a lot of useful oncology news, informing members of the public about new prevention and care treatments. Oncology is a very serious part of the medical branch as it deals with cancer, one of the leading causes of death in the world.
Oncotarget gained a following as a medical journal specifically geared towards educating everyday citizens about oncological health matters, hence the name Oncotarget. Oncotarget did not think it would grow so rapidly however. Because of its quick growth the publication was stuck with a tough decision. To make room for the new growth Oncotarget had to expand its content beyond just oncology.
Andrei V. Gudkov and Mikhail Blagosklonny were in complete agreement when it came to diversifying the journals content. Both editors in chief thought it was a great idea and committed to it fully. Their leadership, skills, and expertise made sure that it was the right choice. Oncotarget took full advantage of the change. It has been a top ranked for a number of years according to multiple reputable sources in the industry. Oncotarget is also available on Dove Press.
Oncotarget’s popularity is through the roof and steadily rising. Readers are attracted to its visionary, constructive, and comprehensive peer view approach. It is so popular it has the ability to dramatically affect the world of oncology, Neuroscience, Endocrinology, Cardiology, etc.
Each weekly issue of Oncotarget is available online on DovePress.com, a free acess site. Its primary goal isn’t to make a buck it’s to make scientific results rapidly and widely available. The best knowledge in the world is useless if only a few people are aware of it. its prominent research team continuously finds creative ways to link different fields of biomedical science. Follow Oncotarget journal on Twitter.
Oncotarget remains consistently great as other journal fluctuate.
The name Eric Lefkofsky may not be a household name, but he is the business strategist behind Groupon, an American worldwide e-commerce marketplace. Although Groupon is the most recognizable, Eric has found similar success with Innerworkings, a marketing firm serving Fortune 500 brands, and Echo Global Logistics, a provider of technology-enabled transportation and supply chain management services. Collectively, these business endeavors have earned Eric Lefkofsky an estimated $1.79 billion over the years, making him one of the most enterprising businessmen in the e-commerce industry and Eric’s lacrosse camp.
Not one to rest on his laurels and recognizing an untapped technology niche in the medical industry; Eric launched Tempus, which is a biotechnology company in Chicago, IL. The Tempus business model is predicated on establishing congruency between technology and medicine; Eric recognized that although physicians were capable of collecting voluminous amounts of patient data, they did not have the necessary means for analyzing it. Tempus’ goal is to create a genomic cancer library, which will allow physicians to compare and analyze the DNA of varying patients. How does this benefit the medical industry? It enables physicians to identify similarities in the genetic profiles of their patients, and these similarities will enable physicians to prescribe a course of therapy with proven efficacy among patients with similar genetic profiles. In layman’s terms, physicians will have immediate access to a library of patient data, and this data aids them in prescribing the best treatment options for patients afflicted with similar cancers and more information click here.
Eric Lefkofsky is by no means a novice when it comes to bridging humanitarian efforts and business. In 2006 Eric, along with his wife Liz, established the Lefkofsky family foundation, which supports charitable, scientific, and educational organizations worldwide. Through this foundation, he and his wife have donated $1 million to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, which is in addition to the $500,000 donated to support immunotherapy for gastric cancer research at Stanford University. Eric’s involvement in cancer research is quite evident; it’s proven not only by his charitable donations but by creating a business that is sure to revolutionize the way physicians access and analyze data and learn more about Eric.
More visit: www.forbes.com/profile/eric-lefkofsky
Tempus is an organization that was formed to assist in battling cancer. Eric Lefkofsky, the Groupon founder, plays a central role in researching on the essence of data in cancer therapies. Currently, Eric is seeking to submit data to the physicians at the University of Chicago. He believes that it will boost their treatment for breast cancer. Tempus decided to partner with the University of Chicago to enable the provision of molecular sequencing and evaluation. By so doing, Tempus would boost UChicago’s breast cancer medics in the creation of customized treatment plans for their patients. As Tempus confidently highlights, their primary objective is to ensure improved patient results.
Essentials to Pick From Tempus’ Decision to Partner WithUChicago
Dr. OlufunmilayoOlopade asserts that there is comparatively little data accessible for breast cancer cases despite being among the most common tumors. The professor of human genetics and medicine says that it is unfortunate, considering that millions of cancer patients have fought futile battles against breast cancer. Dr. Olopade expressed great excitement in partnering with Tempus. Olopade was confident that the partnership would do enough in ascertaining the particular genetic data required in making treatment decisions. The most exciting thing is that they employ the state-of-the-art technology in developing tailor-made solutions.
Basics Surrounding Eric’s Career Life
Eric Lefkofsky is a self-made entrepreneur. Apart from Tempus, he founded and co-founded several other initiatives. Lefkofsky is a founding partner at Lightbank, an enterprise investing their finances in disruptive technologies. Eric also co-founded Groupon, a worldwide online market, where he also serves as the chairman. The influential positions he holds refine his competence significantly. You might also find it fascinating to learn about his co-founding of Uptake Technologies. Mentioned are just a few of the endeavors whose launching Eric actively took part in, which is a great milestone for him. Besides that, Mr. Lefkofsky is also a remarkable philanthropist. He and his wife Liz founded Lefkofsky Family Foundation, a high-impact cause aimed at enhancing lives in the societies served. Such are among the many other charitable organizations that they bankroll.
More visit: https://www.crunchbase.com/person/eric-lefkofsky